Læs og lyt til tusindvis af e- og lydbøger med Saxo Premium Stream e- og lydbøger Prøv gratis
Du sparer 32% Du sparer 32%
Anxiolytics
  • kr. 1.399,95
  • Leveringstid 2-4 uger
  • Forventet levering 24-10-2018
  • 32%
Bog, paperback (kr. 954,95) (kr. 954,95)
  1. Beskrivelse

    In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). 1 Paperback / softback IX, 181 p.

  2. Yderligere info
    Udgivelsesdato:
    01-09-2000
    Sprog:
    Engelsk
    ISBN13:
    9783034895811
    Sidetal:
    190
    Vægt:
    308 g
    Dybde:
    10 mm
    Bredde:
    155 mm
    Højde:
    235 mm
    Forlag:
    Springer Basel
    Mærkat:
    Bog, paperback
    Format:
    Paperback
    Udgave:
    Softcover reprint of the original 1st ed. 2000
    • Bibliotekernes beskrivelse

      For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi- azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal.

  3. Anmeldelser

Fandt du ikke hvad du søgte?

Hvis denne bog ikke er noget for dig, kan du benytte kategorierne nedenfor til at finde andre titler. Klik på en kategori for at se lignende bøger.